About Carolina Specialty Care PA
Services
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Medications for Hepatitis C treatment; Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
SAMHSA certification for opioid treatment program (OTP); Drug Enforcement Agency (DEA)
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; SAMHSA funding/block grants
Assessment/Pre-treatment
Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders; Professional interventionist/educational consultant
Testing
Drug or alcohol urine screening; HIV testing; STD testing; TB screening; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care; Naloxone and overdose education; Outcome follow-up after discharge
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling
Medical Services
Hepatitis B (HBV) vaccination
Facility Smoking Policy
Smoking not permitted
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Medications for Hepatitis C treatment; Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
SAMHSA certification for opioid treatment program (OTP); Drug Enforcement Agency (DEA)
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; SAMHSA funding/block grants
Assessment/Pre-treatment
Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders; Professional interventionist/educational consultant
Testing
Drug or alcohol urine screening; HIV testing; STD testing; TB screening; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care; Naloxone and overdose education; Outcome follow-up after discharge
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling
Medical Services
Hepatitis B (HBV) vaccination
Facility Smoking Policy
Smoking not permitted
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
